WHO ICTRP trial
Effect of intranasal oxytocin on social approach in patients with social phobia…
DRKS00000403 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00000403 |
|---|---|
| Public title | Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control |
| Scientific title | Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control - OXT_fMRT |
| Primary sponsor | Rheinisch-Westfälische Technische Hochschule Aachen vertretn durch das CTC-A der Medizinischen Fakultät der RWTH Aachen |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 4 |
| Countries | Germany |
| Conditions | F40.1;Social phobias;F40.1 |
| Interventions | Group 1: The participants of arm 1 (control subjects) will be examined in two sessions, 2h each, spaced 4 weeks apart. In session 1 they receive a dose of 26 IU oxytocin (Syntocinon®), administered intranasally. In session 2 the equivalent… |
| Registration date | Oct 5, 2010 |
| Target size | 96 |
| Secondary IDs | U1111-1114-8096;2009-015538-30;4036026 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: